MTRF1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.667700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.547800E-01
Normal-vs-Stage2
6.147600E-02
Normal-vs-Stage3
5.841700E-02
Normal-vs-Stage4
4.829400E-01
Stage1-vs-Stage2
6.165600E-01
Stage1-vs-Stage3
2.664400E-01
Stage1-vs-Stage4
5.967200E-01
Stage2-vs-Stage3
1.533010E-01
Stage2-vs-Stage4
2.210000E-01
Stage3-vs-Stage4
5.993900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.976300E-02
Normal-vs-AfricanAmerican
4.509600E-01
Normal-vs-Asian
1.628760E-01
Caucasian-vs-AfricanAmerican
3.222000E-01
Caucasian-vs-Asian
7.741000E-01
AfricanAmerican-vs-Asian
5.791000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.402300E-02
Normal-vs-Female
9.956300E-02
Male-vs-Female
2.811800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.315830E-01
Normal-vs-Age(41-60Yrs)
2.852200E-01
Normal-vs-Age(61-80Yrs)
2.712300E-02
Normal-vs-Age(81-100Yrs)
3.711600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.763600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.818000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.279000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.402790E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.609600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.113400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.999940E-02
Normal-vs-Daily Drinker
4.562700E-03
Normal-vs-Weekly Drinker
2.480800E-01
Normal-vs-Occasional Drinker
3.224400E-01
Normal-vs-Social Drinker
1.887610E-01
Non Drinker-vs-Daily Drinker
5.053200E-01
Non Drinker-vs-Weekly Drinker
1.069800E-01
Non Drinker-vs-Occasional Drinker
3.054400E-02
Non Drinker-vs-Social Drinker
1.146820E-01
Daily Drinker-vs-Weekly Drinker
3.522400E-02
Daily Drinker-vs-Occasional Drinker
8.656900E-03
Daily Drinker-vs-Social Drinker
3.417900E-02
Weekly Drinker-vs-Occasional Drinker
7.270000E-01
Weekly Drinker-vs-Social Drinker
9.201600E-01
Occasional Drinker-vs-Social Drinker
6.343800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.770400E-01
Normal-vs-Grade 2
8.782000E-01
Normal-vs-Grade 3
9.299600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.788600E-01
Grade 1-vs-Grade 3
4.306200E-01
Grade 1-vs-Grade 4
8.770400E-01
Grade 2-vs-Grade 3
2.835800E-01
Grade 2-vs-Grade 4
8.782000E-01
Grade 3-vs-Grade 4
9.299600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.148300E-02
Normal-vs-NonDiabetic
5.010100E-02
Diabetic-vs-NonDiabetic
3.492600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.398040E-02
Normal-vs-NoPancreatitis
5.566400E-02
Pancreatitis-vs-NoPancreatitis
2.689400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.910400E-02
Normal-vs-N1
6.506200E-02
N0-vs-N1
9.284400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.854400E-02
Normal-vs-TP53-NonMutant
1.622560E-01
TP53-Mutant-vs-TP53-NonMutant
4.022600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
